Reactivation of p53 by a Cytoskeletal Sensor to Control the Balance Between DNA Damage and Tumor DisseminationCecilia Herráiz, Victoria Sanz‐Moreno, Fernando Calvo et al.|JNCI Journal of the National Cancer Institute|2015Cited by 181
Protocolisation, Use and Development of Anti-Cancer Drugs in the Context of T2A (Case-Mix Based Payment System) Set-UpA. Mathieu-Boué, Patrice Viens, C. Atlani et al.|Therapies|2006Cited by 0